Mezzion Pharmaceuticals leverages its extensive experience in drug development and clinical trials, driven by a strong sense of compassion, to discover, develop, and deliver new treatments for rare diseases. Their vision is to ensure that no patient with a rare disease is left without hope, particularly focusing on Single Ventricle Heart Disease.